Salarius Pharmaceuticals Overview

  • Founded
  • 2011
  • Status
  • Public
  • Employees
  • 8
  • Stock Symbol
  • SLRX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $1.22
  • (As of Tuesday Closing)

Salarius Pharmaceuticals General Information


Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.

Contact Information

Formerly Known As
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 2450 Holcombe Boulevard
  • Suite X
  • Houston, TX 77021
  • United States
+1 (203) 000-0000

Salarius Pharmaceuticals Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Salarius Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.22 $1.21 $0.56 - $3.16 $24.2M 19.8M 973K -$0.84

Salarius Pharmaceuticals Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 9,504 12,128 (7,000) 23,542
Revenue 4,793 3,465 838 1,274
EBITDA (7,447) (6,826) (21,846) (34,401)
Net Income (7,468) (6,936) (21,922) (34,434)
Total Assets 23,063 13,894 10,390 34,993
Total Debt 761 502 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Salarius Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Salarius Pharmaceuticals‘s full profile, request access.

Request a free trial

Salarius Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
David Arthur Chief Executive Officer & Board Member
Mark Rosenblum Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Bruce McCreedy Ph.D Chief Scientific Officer & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

Salarius Pharmaceuticals Board Members (17)

Name Representing Role Since
Arnold Hanish Self Board Member 000 0000
Bruce McCreedy Ph.D Self Chief Scientific Officer & Board Member 000 0000
David Arthur Salarius Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Jonathan Lieber Self Board Member 000 0000
Jonathan Northrup Salarius Pharmaceuticals Chairman & Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Salarius Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Salarius Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 19-Jul-2019 000000000000000000 000.00 Drug Discovery 00000 000000
To view Salarius Pharmaceuticals’s complete acquisitions history, request access »